Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Mastercard IncMA · Entity 1763 | Director | June 25, 2019 | June 27, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Mastercard Inc
Report date June 25, 2019 · Filed June 27, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 55,266 |
Reported balance
After 2019-06-25 transaction · row 1
1 source rowRow 1 · 2019-06-25 · Grant · Acquired 828 · Balance 55,266 F1: Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan. The award was fully vested on June 25, 2019, the date of grant, but will settle on June 25, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan. The award was fully vested on June 25, 2019, the date of grant, but will settle on June 25, 2023.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Keenova Therapeutics plc
Report date June 16, 2022 · Filed June 21, 2022
Section 16 reporting ended · disclosed 2022-06-21. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 07, 2020 Filed Dec 7, 2020 16:32 UTC | Keenova Therapeutics plc MNKKQ · Entity 28960 | SaleOrdinary Shares | 16,020 | $0.14 | $2,197.94 |
DisclosureSEC source: 0000950138-20-000523 · edgar.xml · nonDerivative · entry 2 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 16:32 UTC | Keenova Therapeutics plc MNKKQ · Entity 28960 | SaleOrdinary Shares | 31,087 | $0.14 | $4,482.75 |
DisclosureSEC source: 0000950138-20-000523 · edgar.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,020 F1 · price: The price represents a weighted average. The shares were sold in multiple transactions at prices ranging from $0.140 to $0.148, inclusive. Mr. Carlucci will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range. Read SEC document |
| May 13, 2020 Filed May 15, 2020 16:08 UTC | Keenova Therapeutics plc MNK · Entity 28960 | Tax withholdingOrdinary Shares | 8,729 | $2.96 | $25,837.84 |
DisclosureSEC source: 0000950138-20-000253 · edgar.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,107 Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 19:22 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 828 | $0.00 | $0.00 |
DisclosureSEC source: 0001141391-19-000118 · wf-form4_156166332183720.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,266 F1 · shares: Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan. The award was fully vested on June 25, 2019, the date of grant, but will settle on June 25, 2023. Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 20:08 UTC | Mastercard Inc MA · Entity 1763 | SaleClass A Common Stock | 3,974 | $262.51 | $1,043,208.78 |
DisclosureSEC source: 0001141391-19-000084 · wf-form4_156037012254779.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,438 F1 · price: This transaction was executed in multiple trades at prices ranging from $262.46 to $262.57. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 15, 2019 Filed May 17, 2019 06:45 UTC | Keenova Therapeutics plc MNK · Entity 28960 | GrantOrdinary Shares | 19,396 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000304 · edgar.xml · nonDerivative · entry 2 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,836 F1 · shares: Consists of restricted stock units that vest in their entirety as of the date of the Company's 2020 Annual General Meeting. The restricted stock units settle in ordinary shares upon vesting. Read SEC document |
| May 15, 2019 Filed May 17, 2019 06:45 UTC | Keenova Therapeutics plc MNK · Entity 28960 | Tax withholdingOrdinary Shares | 8,527 | $15.21 | $129,695.67 |
DisclosureSEC source: 0000950138-19-000304 · edgar.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,440 Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 16:02 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 993 | $0.00 | $0.00 |
DisclosureSEC source: 0001141391-18-000102 · wf-form4_153020172826836.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,412 F1 · shares: Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan. The award was fully vested on June 26, 2018, the date of grant, but will be settled on June 26, 2022. Read SEC document |
| May 16, 2018 Filed May 18, 2018 16:25 UTC | Keenova Therapeutics plc MNK · Entity 28960 | GrantOrdinary Shares | 18,947 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-18-000417 · edgar.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,967 F1 · shares: Consists of restricted stock units that vest in their entirety as of the date of the Company's 2019 Annual General Meeting. The restricted stock units settle in ordinary shares upon vesting. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 20:15 UTC | Mastercard Inc MA · Entity 1763 | SaleClass A Common Stock | 5,950 | $183.10 | $1,089,453.33 |
DisclosureSEC source: 0001141391-18-000029 · wf-form4_152088570922971.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,419 Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 16:04 UTC | Keenova Therapeutics plc MNK · Entity 28960 | PurchaseOrdinary Shares | 10,000 | $21.83 | $218,349.00 |
DisclosureSEC source: 0000950138-17-000746 · edgar.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,020 Read SEC document |
| October 01, 2017 Filed Oct 3, 2017 17:02 UTC | Keenova Therapeutics plc MNK · Entity 28960 | Tax withholdingOrdinary Shares | 476 | $37.37 | $17,788.12 |
DisclosureSEC source: 0000950138-17-000702 · edgar.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,020 Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 19:27 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 1,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001141391-17-000107 · wf-form4_149876442353087.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,369 F1 · shares: Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan. The award was fully vested on June 27, 2017, the date of grant, but will be settled on June 27, 2021. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 19:00 UTC | Keenova Therapeutics plc MNK · Entity 28960 | Tax withholdingOrdinary Shares | 2,286 | $51.55 | $117,843.30 |
DisclosureSEC source: 0000950138-17-000268 · edgar.xml · nonDerivative · entry 2 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,496 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 19:00 UTC | Keenova Therapeutics plc MNK · Entity 28960 | GrantOrdinary Shares | 5,723 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-17-000268 · edgar.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,782 F1 · shares: Consists of restricted stock units that vest in their entirety as of March 1, 2018. The restricted stock units settle in ordinary shares upon vesting. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 08:51 UTC | Keenova Therapeutics plc MNK · Entity 28960 | GrantOrdinary Shares | 1,057 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-16-001367 · edgar.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,059 F1 · shares: Consists of restricted stock units that vest in their entirety as of October 1, 2017. The restricted stock units settle in ordinary shares upon vesting. Read SEC document |
| June 28, 2016 Filed Jun 29, 2016 21:04 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 2,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001141391-16-000189 · wf-form4_146723424290026.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,861 F1 · shares: Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan. The award was fully vested on June 28, 2016, the date of grant, but will be settled on June 28, 2020. Read SEC document |
| June 09, 2015 Filed Jun 11, 2015 17:34 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 2,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-013704 · doc4.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,814 F1 · price: Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan. The award was fully vested on June 9, 2015, the date of the grant, but will be settled on June 9, 2019. Read SEC document |
| June 03, 2014 Filed Jun 5, 2014 21:05 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-014579 · doc4.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,805 F1 · price: Represents deferred stock unit award pursuant to the terms of a stockholder-approved non-employee director equity compensation plan. The award will be settled on June 3, 2018. Read SEC document |
| June 18, 2013 Filed Jun 20, 2013 20:30 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 257 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-014664 · doc4.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,584 F1 · price: Represents deferred stock unit award pursuant to the terms of a stockholder-approved director equity compensation plan. The award will settle on the date of termination of the reporting person's service as a director. Read SEC document |
| June 05, 2012 Filed Jun 8, 2012 01:11 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 319 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-014014 · doc4.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,327 F1 · price: Represents deferred stock unit award pursuant to the terms of a stockholder-approved director equity compensation plan. The award will be settled on June 5, 2016. Read SEC document |
| June 07, 2011 Filed Jun 9, 2011 20:33 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-11-035943 · rrd314855.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,008 F1 · price: Represents deferred stock unit award pursuant to the terms of a shareholder-approved director equity compensation plan. The award will be settled on June 7, 2015. Read SEC document |
| September 21, 2010 Filed Sep 23, 2010 20:38 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 461 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-10-047789 · rrd285969.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,643 F1 · price: Represents deferred stock unit award pursuant to the terms of a shareholder-approved director equity compensation plan. The award will be settled on September 21, 2014. Read SEC document |
| June 09, 2009 Filed Jun 11, 2009 22:06 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 595 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-09-030253 · rrd245578.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,182 F1 · price: Represents deferred stock unit award pursuant to the terms of the MasterCard Incorporated 2006 Non-Employee Director Equity Compensation Plan, as amended and restated, which was approved by stockholders of MasterCard Incorporated (the ?Company?) at the Company?s 2006 annual meeting of stockholders held on July 18, 2006. The award will be settled on June 9, 2013. Read SEC document |
| June 03, 2008 Filed Jun 5, 2008 21:13 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-037150 · rrd209272.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,587 F1 · price: Represents deferred stock unit award pursuant to the terms of the MasterCard Incorporated 2006 Non-Employee Director Equity Compensation Plan, which was approved by stockholders of MasterCard Incorporated (the "Company") at the Company's July 18, 2006 annual meeting of stockholders. The award will be settled on June 3, 2012. Read SEC document |
| June 07, 2007 Filed Jun 11, 2007 21:17 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 697 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-07-039230 · rrd161861.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,262 F1 · price: Represents deferred stock unit award pursuant to the terms of the MasterCard Incorporated 2006 Non-Employee Director Equity Compensation Plan, which was approved by stockholders of MasterCard Incorporated (the "Company") at the Company's July 18, 2006 annual meeting of stockholders. The award will be settled on June 7, 2011. Read SEC document |
| July 18, 2006 Filed Jul 19, 2006 21:42 UTC | Mastercard Inc MA · Entity 1763 | GrantClass A Common Stock | 2,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-042746 · rrd124718.xml · nonDerivative · entry 1 CARLUCCI DAVID R · CIK 0001201564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,565 F1 · price: Deferred Stock Unit award pursuant to the terms of the 2006 Non-Employee Director Equity Compensation Plan, which was approved by stockholders at MasterCard Incorporated's July 18, 2006 annual meeting of stockholders; the award will be settled on July 18, 2010 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.